Prevalence of antibodies to SARS-CoV-2 in healthy blood donors in New York
Authors:
- Kathy KamathKKKathy Kamath
- Elisabeth Baum-JonesEBElisabeth Baum-Jones
- Gregory JordanGJGregory Jordan
- Winston HaynesWHWinston Haynes
- Rebecca WaitzRWRebecca Waitz
- John ShonJSJohn Shon
- Steve KujawaSKSteve Kujawa
- Lyn FitzgibbonsLFLyn Fitzgibbons
- Debra KesslerDKDebra Kessler
- Larry L LuchsingerLLLarry L Luchsinger
- Yale Impact TeamYTYale Impact Team
- Patrick DaughertyPDPatrick Daugherty
Preprint
Abstract
Despite the high level of morbidity and mortality worldwide, there is increasing evidence for asymptomatic carriers of the novel coronavirus SARS-CoV-2. We analyzed blood specimens from 1,559 healthy blood donors, collected in the greater New York metropolitan area between the months of March and July 2020 for antibodies to SARS-CoV-2 virus. Using our proprietary technology, SERA (Serum Epitope Repertoire Analysis), we observed a significant increase in SARS-CoV-2 seropositivity rates over the four-month period, from 0% [95% CI: 0 - 1.5%] (March) to 11.6% [6.0 - 21.2%] (July). Follow-up ELISA tests using S1 and nucleocapsid viral proteins confirmed most of these results. Our findings are consistent with seroprevalence studies within the region and with reports that SARS-COV-2 infections can be asymptomatic or cause only mild symptoms. IMPORTANCE: The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has caused vast morbidity and mortality worldwide, yet several studies indicate that there may be a significant number of infected people who are asymptomatic or exhibit mild symptoms. In this study, samples were collected from healthy blood donors in a region of rapidly increasing disease burden (New York metropolitan area) and we hypothesized that a subset would be seropositive to SARS-CoV-2. People who experienced mild or no symptoms during SARS-CoV-2 infection may represent a source for convalescent plasma donors.Keywords
This publication has 6 references indexed in Scilit:
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020JAMA Internal Medicine, 2020
- Cumulative incidence and diagnosis of SARS-CoV-2 infection in New YorkmedRxiv, 2020
- Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serologyScientific Reports, 2020
- Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)International Journal of Infectious Diseases, 2020
- Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencingScientific Reports, 2016
- Biospecimen Reporting for Improved Study Quality (BRISQ)Journal of Proteome Research, 2011